The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Preclinical experimental models of drug metabolism and disposition in drug discovery and development
Open accessAbstract
Drug discovery and development involve the utilization of in vitro and in vivo experimental models. Different models, ranging from test tube experiments to cell cultures, animals, healthy human subjects, and even small numbers of patients that are involved in clinical trials, are used at different stages of drug discovery and development for determination of efficacy and safety. The proper selection and applications of correct models, as well as appropriate data interpretation, are critically important in decision making and successful advancement of drug candidates. In this review, we discuss strategies in the applications of both in vitro and in vivo experimental models of drug metabolism and disposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Valentin, J. (2002) · Annals of the ICRP · doi:10.1016/s0146-6453(03)00002-2 · Cited by 1,754
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery
Polli, J. W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O., & Serabjit-Singh, C. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29270-3 · Cited by 662
Role of CYP2E1 in the Hepatotoxicity of Acetaminophen
Lee, S. S. T., Buters, J. T. M., Pineau, T., Fernandez-Salguero, P., & Gonzalez, F. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.12063 · Cited by 656
Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
Raghavan, N., Frost, C. E., Yu, Z., He, K., Zhang, H., Humphreys, W. G., Pinto, D., Chen, S., Bonacorsi, S., Wong, P. C., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023143 · Cited by 612
Self-citationBiotransformation of Xenobiotics
Timbrell, J. A., & Marrs, T. C. (2009) · General, Applied and Systems Toxicology · doi:10.1002/9780470744307.gat004 · Cited by 435
Buters, J. T. M., Sakai, S., Richter, T., Pineau, T., Alexander, D. L., Savas, U., Doehmer, J., Ward, J. M., Jefcoate, C. R., & Gonzalez, F. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1977 · Cited by 383
Li, A. P., Lu, C., Brent, J. A., Pham, C., Fackett, A., Ruegg, C. E., & Silber, P. M. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00088-5 · Cited by 302
Self-citationPharmaceutical profiling in drug discovery
Kerns, E. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02649-7 · Cited by 288
Profiling drug-like properties in discovery research
Di, L., & Kerns, E. H. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00055-3 · Cited by 278
Henderson, C. J., Otto, D. M. E., Carrie, D., Magnuson, M. A., McLaren, A. W., Rosewell, I., & Wolf, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212087200 · Cited by 258
Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Hirano, M., Maeda, K., Matsushima, S., Nozaki, Y., Kusuhara, H., & Sugiyama, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014019 · Cited by 256
Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism
van Herwaarden, A. E., Wagenaar, E., van der Kruijssen, C. M. M., van Waterschoot, R. A. B., Smit, J. W., Song, J.-Y., van der Valk, M. A., van Tellingen, O., van der Hoorn, J. W. A., Rosing, H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33435 · Cited by 235
Uno, S., Dalton, T. P., Dragin, N., Curran, C. P., Derkenne, S., Miller, M. L., Shertzer, H. G., Gonzalez, F. J., & Nebert, D. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021501 · Cited by 227
Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration
Liu, X., LeCluyse, E. L., Brouwer, K. R., Gan, L.-S. L., Lemasters, J. J., Stieger, B., Meier, P. J., & Brouwer, K. L. R. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.1.g12 · Cited by 226
Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene
Gu, J., Weng, Y., Zhang, Q.-Y., Cui, H., Behr, M., Wu, L., Yang, W., Zhang, L., & Ding, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303125200 · Cited by 214
Self-citationLu, C., & Li, A. P. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00162-4 · Cited by 203
Self-citationMatsushima, S., Maeda, K., Kondo, C., Hirano, M., Sasaki, M., Suzuki, H., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085589 · Cited by 190
THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
Cheung, C., Yu, A.-M., Ward, J. M., Krausz, K. W., Akiyama, T. E., Feigenbaum, L., & Gonzalez, F. J. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002402 · Cited by 167
Shibata, Y., Takahashi, H., Chiba, M., & Ishii, Y. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.892 · Cited by 167
Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.
Liang, H. C., Li, H., McKinnon, R. A., Duffy, J. J., Potter, S. S., Puga, A., & Nebert, D. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1671 · Cited by 159
Casarett and Doull's toxicology
Klaassen, C. D., & Watkins, J. B. (2013) · Cited by 140
Corchero, J., Granvil, C. P., Akiyama, T. E., Hayhurst, G. P., Pimprale, S., Feigenbaum, L., Idle, J. R., & Gonzalez, F. J. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1260 · Cited by 140
Use of Ca2+ Modulation to Evaluate Biliary Excretion in Sandwich-Cultured Rat Hepatocytes
Liu, X., LeCluyse, E. L., Brouwer, K. R., Lightfoot, R. M., Lee, J. I., & Brouwer, K. L. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38310-7 · Cited by 133
Cheung, C., & Gonzalez, F. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141242 · Cited by 129
Shitara, Y., Li, A. P., Kato, Y., Lu, C., Ito, K., Itoh, T., & Sugiyama, Y. (2003) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.18.33 · Cited by 116
Self-citationDalton, T. P., Dieter, M. Z., Matlib, R. S., Childs, N. L., Shertzer, H. G., Genter, M. B., & Nebert, D. W. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1913 · Cited by 115
Gu, J., Cui, H., Behr, M. J., Li, Z., Zhang, Q.-Y., Yang, W., Hinson, J., & Ding, X. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007898 · Cited by 112
Self-citationComparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans
Zhang, D., He, K., Raghavan, N., Wang, L., Mitroka, J. G., Maxwell, B. D., Knabb, R. M., Frost, C. E., Schuster, A. E., Feng, H., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025981 · Cited by 108
Self-citationGranvil, C. P., Yu, A., Elizondo, G., Akiyama, T. E., Cheung, C., Feigenbaum, L., Krausz, K. W., & Gonzalez, F. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.5.548 · Cited by 106
Zhou, X. H., Zhuo, X., Xie, F., Kluetzman, K., Shu, Y., Humphreys, W. G., & Ding, X. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162610 · Cited by 92
Self-citationHariparsad, N., Carr, B., Evers, R., & Chu, X. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020677 · Cited by 91
McGinnity, D. F., Zhang, G., Kenny, J. R., Hamilton, G. A., Otmani, S., Stams, K. R., Haney, S., Brassil, P. J., Stresser, D. M., & Riley, R. J. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026526 · Cited by 90
Cheung, C., Yu, A., Chen, C.-S., Krausz, K. W., Byrd, L. G., Feigenbaum, L., Edwards, R. J., Waxman, D. J., & Gonzalez, F. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094367 · Cited by 88
Drug Metabolism in Drug Design and Development: Basic Concepts and Practice
(2007) · Wiley eBooks · doi:10.1002/9780470191699 · Cited by 87
Li, L., Wei, Y., Winkle, L. S. V., Zhang, Q., Zhou, X. H., Hu, J., Xie, F., Kluetzman, K., & Ding, X. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184671 · Cited by 82
Self-citationJiang, Z., Dalton, T. P., Li, J., Wang, B., Tsuneoka, Y., Shertzer, H. G., Deka, R., & Nebert, D. W. (2005) · Human Mutation · doi:10.1002/humu.20134 · Cited by 81
EVALUATION OF TIME-DEPENDENT INACTIVATION OF CYP3A IN CRYOPRESERVED HUMAN HEPATOCYTES
Zhao, P., Kunze, K. L., & Lee, C. A. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002832 · Cited by 78
Strelevitz, T. J., Orozco, C. C., & Obach, R. S. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045195 · Cited by 77
Li, A. P., Hartman, Lu, Collins, & strong (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00081.x · Cited by 71
Nakano, H., Ogura, K., Takahashi, E., Harada, T., Nishiyama, T., Muro, K., Hiratsuka, A., Kadota, S., & Watabe, T. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.216 · Cited by 70
Wu, L., Gu, J., Cui, H., Zhang, Q.-Y., Behr, M. J., Fang, C., Weng, Y., Kluetzman, K., Swiatek, P. J., Yang, W., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073353 · Cited by 67
Self-citationLu, C., Miwa, G. T., Prakash, S. R., Gan, L.-S. L., & Balani, S. K. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011346 · Cited by 66
Self-citation(2004) · PubMed · Cited by 66
Blanchard, N., Hewitt, N. J., Silber, P. M., Jones, H. M., Coassolo, P., & Lavé, T. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.5.0008 · Cited by 64
Zhang, D., Raghavan, N., Chen, S.-Y., Zhang, H., Quan, M. L. C., Lecureux, L. W., Patrone, L. M., Lam, P. Y. S., Bonacorsi, S. J., Knabb, R. M., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018416 · Cited by 55
Self-citationLöfgren, S., Baldwin, R. M., Hiratsuka, M., Lindqvist, A., Carlberg, A., Sim, S. C., Schuelke, M., Snait, M., Edenro, A., Fransson-Steen, R., et al. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019349 · Cited by 50
Zhang, Q., Fang, C., Zhang, J., Dunbar, D. A., Kaminsky, L. S., & Ding, X. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025429 · Cited by 50
Self-citationParker, R., Hirom, P. C., & Millburn, P. (1980) · Xenobiotica · doi:10.3109/00498258009108376 · Cited by 46
Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes
Bachmann, K. A., Byers, J. P., & Ghosh, R. (2003) · Xenobiotica · doi:10.1080/0049825031000076177 · Cited by 44
van Herwaarden, A. E., Smit, J. W., Sparidans, R. W., Wagenaar, E., van der Kruijssen, C. M. M., Schellens, J. H. M., Beijnen, J. H., & Schinkel, A. H. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004721 · Cited by 43
Transporter-mediated uptake into cellular compartments
Oswald, S., Grube, M., Siegmund, W., & Kroemer, H. K. (2007) · Xenobiotica · doi:10.1080/00498250701570251 · Cited by 41
Role of Small Intestinal Cytochromes P450 in the Bioavailability of Oral Nifedipine
Zhang, Q.-Y., Kaminsky, L. S., Dunbar, D. A., Zhang, J., & Ding, X. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016543 · Cited by 40
Self-citationKitamura, S., Maeda, K., & Sugiyama, Y. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0312-9 · Cited by 36
Retention of Transporter Activities in Cryopreserved, Isolated Rat Hepatocytes
Houle, R., Raoul, J., Lévesque, J.-F., Pang, K. S., Nicoll‐Griffith, D. A., & Silva, J. M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.4.447 · Cited by 35
Wang, L., Zhang, D., Swaminathan, A., Xue, Y., Cheng, P. T. W., Wu, S. C., Mosqueda‐Garcia, R., Aurang, C., Everett, D. W., & Humphreys, W. G. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007617 · Cited by 35
Self-citationThe Use of Hepatocytes to Investigate Drug Uptake Transporters
Maeda, K., & Sugiyama, Y. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-688-7_18 · Cited by 33
Zhang, D., Wang, L., Raghavan, N., Zhang, H., Li, W., Cheng, P. T. W., Yao, M., Zhang, L., Zhu, M., Bonacorsi, S. J., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012450 · Cited by 30
Self-citationFang, C., Gu, J., Xie, F., Behr, M. J., Yang, W., Abel, E. D., & Ding, X. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021881 · Cited by 29
Self-citationSkaggs, S. M., Foti, R., & Fisher, M. B. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.10.002 · Cited by 26
Generation and characterization of a transgenic mouse model with hepatic expression of human CYP2A6
Zhang, Q.-Y., Gu, J., Su, T., Cui, H., Zhang, X., D’Agostino, J., Zhuo, X., Yang, W., Swiatek, P. J., & Ding, X. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.086 · Cited by 26
Self-citationUse ofin vitrotransporter assays to understand hepatic and renal disposition of new drug candidates
Sahi, J. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.3.409 · Cited by 25
Combining high-throughput pharmacokinetic screens at the hits-to-leads stage of drug discovery
Spalding, D. J. M., Harker, A. J., & Bayliss, M. K. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)00061-1 · Cited by 19
Wei, Y., Zhou, X., Fang, C., Li, L., Kluetzman, K., Yang, W., Zhang, Q.-Y., & Ding, X. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167411 · Cited by 16
Self-citationMetabolic Stability Screen in Drug Discovery
Lu, C. (2014) · Wiley eBooks · doi:10.1002/9781118541203.xen0021 · Cited by 4
Self-citation
Cited by
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Deuterium‐ and Tritium‐Labelled Compounds: Applications in the Life Sciences
Atzrodt, J., Derdau, V., Kerr, W. J., & Reid, M. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201704146 · Cited by 810
Drug metabolism in drug discovery and development
Zhang, Z., & Tang, W. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.04.003 · Cited by 360
Sahlgren, C., Meinander, A., Zhang, H., Cheng, F., Preis, M., Xu, C., Salminen, T. A., Toivola, D., Abankwa, D., Rosling, A., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700258 · Cited by 315
Bagheri, S., TermehYousefi, A., & Do, T.-O. (2017) · Catalysis Science & Technology · doi:10.1039/c7cy00468k · Cited by 302
Metadata
- Authors
- Zhang, D., Luo, G., Ding, X., & Lu, C.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 2
- Issue
- 6
- Pages
- 549-561
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W2027117428
- Cited by
- 309
- References
- 66
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.